Seroprevalence of IgG Antibodies against Echinococcus granulosus in the Population of the Region of Thessaly, Central Greece

Echinococcosis notification rate in Greece, based on the most recent data, is below 0.25 per 100,000 population. To further investigate the epidemiology of echinococcosis in Greece a study was designed to determine the seroprevalence of Echinococcus granulosus antibodies in the population of Thessaly, Central Greece. Five hundred and forty two left over blood samples in Thessaly laboratories, were collected using a stratified convenient sampling procedure. Samples were analyzed with enzyme linked immunosorbent assay. The seropositivity found was 1.1%(95% C.I., 0.5–2.5), with 5 out of 6 seropositive results to be in the age group of over 65 (OR = 17.95, 95%CI 2.04–157.11, p value 0.009). Rural residence was also found as a risk factor to seropositivity (RR = 7.60, 95% CI 0.89–64.64, p value 0.039). Surveillance data and our study results converge that echinococcosis is being reduced in Greece, with older population to be affected mostly. These might be due to the disease transmission restriction, by the control measures being implemented. Efforts should be continued, in both animals and humans side, by increasing training campaigns and public awareness.

[1]  S. Sotiraki,et al.  Cystic echinococcosis in Greece. Past and present. , 2010, Parasite.

[2]  M. Falagas,et al.  Decreasing trends of ultrasonographic prevalence of cystic echinococcosis in a rural Greek area , 2010, European Journal of Clinical Microbiology & Infectious Diseases.

[3]  H. Zeller,et al.  [Tropical arboviral diseases and their implications for Europe: role of the European Centre for Disease Prevention and Control (ECDC)]. , 2009, Medecine tropicale : revue du Corps de sante colonial.

[4]  Pedro Moro,et al.  Echinococcosis: a review. , 2009, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[5]  B. Šoba,et al.  Serological evidence for human cystic echinococcosis in Slovenia , 2008, BMC infectious diseases.

[6]  R. Gilman,et al.  Diagnosis of Cystic Echinococcosis, Central Peruvian Highlands , 2008, Emerging infectious diseases.

[7]  R. Gilman,et al.  Prevention and control of cystic echinococcosis. , 2007, The Lancet. Infectious diseases.

[8]  D. Carmena,et al.  Antigens for the immunodiagnosis of Echinococcus granulosus infection: An update. , 2006, Acta tropica.

[9]  A. Nardone,et al.  Serological surveillance of rubella in Europe: European Sero-Epidemiology Network (ESEN2). , 2004, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[10]  M. Struelens.  How Europe is facing up to antibiotic resistance. , 2004, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[11]  Miguel Ángel Bratos,et al.  Seroprevalencia de infección por Echinococcus granulosus en la población de Castilla y León , 2003 .

[12]  D. McManus,et al.  Concepts in Immunology and Diagnosis of Hydatid Disease , 2003, Clinical Microbiology Reviews.

[13]  A. Dueñas,et al.  [Seroprevalence of infection due to Echinococcus granulosus in the population of Castilla and León (Spain)]. , 2003, Enfermedades infecciosas y microbiologia clinica.

[14]  M. Antoniou,et al.  Fourteen-year seroepidemiological study of zoonoses in a Greek village. , 2002, The American journal of tropical medicine and hygiene.